(7 x M) at 36 .t 0.5'C in mixed air:5% Cog. During 120 hours of cu1ture:l)CON explants increased in size and demonstrated advanced tubular differentiation; and 2) CPK explants, which initially exhibited prominent proximal tubular dilatation and cyst formation, demonstrated total cyst regression in addition to overall growth and differentiation similar to CON.
We conclude that in the CPK animal model of PKD: 1) early changes of proximal tubular cyst formation are totally reversible in vitro; and therefore that 2) genetically determined cyst --formation can be modified by environmental factors. MOC of CPK kidneys provides a controlled experimental system in which the enviromental factors modulating cystic organogenesis may be isolated and further characterized.
MULTICENTER STUDY OF SERUM ERYTHROPOIETIN AND PTH

LEVELS I N CHILDREN WITH CHRONIC RENAL FAILURE.
Barbara S. Beckman and James W. Fisher. (Spon. by John Lewy) f o r t h e Southwest P e d i a t r i c Nephrology Study Group, Tulane U n i v e r s i t y School o f Medicine, Departments o f Pharmacology and P e d i a t r i c s , New Orleans, LA.
The r e l a t i v e r o l e s o f e r y t h r o p o i e t i n (Ep) d e f i c i e n c y and PTH excess i n t h e development o f anemia i n c h i l d r e n w i t h chronic renal f a i l u r e (CRF) have been assessed. Serum Ep i n 71 p a t i e n t s (PTS) was determined by radioimmunoassay (RIA). Seven were s t u d i e d i n the p r e d i a l y s i s stage, 32 on hemodialysis, 16 on CAPD and 16 on CCPD. The mean serum Ep was 38.753.5 mu/ml w i t h anemia o f renal disease ( p r e d i a l y s i s and d i a l y s i s PTS) compared t o 19.6 t1.5 mulml i n normals. However, when compared t o 30 c h i l d r e n -w i t h anemia o f non-renal o r i g i n , t h e e l e v a t i o n i n Ep (range 28.7-327 mulml) was s i g n i f i c a n t l y below t h a t expected f o r t h e degree o f anemia i n these renal disease PTS. W e also found a d i r e c t i n h i b i t o r y e f f e c t o f uremic serum on both immunologic and b i o l o g i c a c t i v i t y o f Ep i t s e l f . Co-incubation o f Ep (50,100, o r 200 mulml) w i t h uremic serum r e s u l t e d i n markedly lower RIA values f o r these three concentrations o f Ep compared t o normal serum. B i o l o g i c a c t i v i t y as assessed i n t h e f e t a l mouse l i v e r CFU-E assay was also decreased w i t h uremic serum. Serum PTH l e v e l s , although elevated, d i d n o t c o r r e l a t e w i t h the degree o f anemia. I n conclusion although r e l a t i v e Ep d e f i c i e n c y plays a primary r o l e i n t h e anemia o f CRF o t h e r f a c t o r s which a l t e r Ep i t s e l f and i n h i b i t e r y t h r o i d progenitors appear t o be involved.
IDIOPATHIC NEPHROTIC SYNDROME: LONG-TERM PROGNOSIS.
Gaudio, N.J. Siegel, Yale Dept. o f Pediatr., New Haven, CT.
The c l i n i c a l course o f i d i o p a t h i c nephrotic syndrome was
studied i n 65 c h i l d r e n (mean age 3.3 y r s , range 1-14 y r s ) who were e i t h e r s t e r o i d responsive (61 p t s ) o r had s t e r o i d -r e s i s t a n t minimal change disease ( 4 p t s ) a t onset. A l l p t s were followed f o r a minimum of 10 y r s (range 10-25 y r s ) and follow-up was 15 y r s i n 29 p t s (45%).
Of t h e 61 s t e r o i d responsive pts, 53 had a f r e q u e n t l y relapsi n g -s t e r o i d dependent course. Of these p t s , 20 were t r e a t e d w i t h cytoxan which induced a permanent remission i n 13 (mean d u r a t i o n 8.7 y r s , range 6-12 y r s ) and s i g n i f i c a n t l y reduced the r a t e o f relapses i n 4 others. Of the 33 p t s n o t given cytoxan, 35% cont i n u e t o experience relapses 10-18 y r s a f t e r onset w h i l e the o t h e r s have been i n remission f o r t h e past 2-16 y r s (mean 7.6 v r s ) .
. . -, Of the 4 p t s w i t h s t e r o i d r e s i s t a n t minimal change disease, 3 were t r e a t e d w i t h cytoxan and a l l achieved a remission. Two o f these p t s have had no relapses 10 and 12 y r s a f t e r onset and 1 p t had a s i n g l e relapse.
A t t h e completion o f follow-up (mean 14.4 y r s ) , a l l p t s have normal renal f u n c t i o n (SCr C 1.5 mgldl ), 17% have BP 1 140180 and 76% have a h e i g h t which i s c 5 0 % t i l e (adjusted f o r sex and age) w h i l e 33% a r e L 2 5 % t i l e f o r height. These f i n d i n g s suggest t h a t i n c h i l d r e n w i t h s t e r o i d responsive NS o r s t e r o i d r e s i s t a n t m i n imal change disease there i s : a ) a favorable long-term outcome; b ) t h e d u r a t i o n of r e l a p s i n g disease i s reduced by treatment w i t h c toxan and c ) s h o r t s t a t u r e i s a s i g n i f i c a n t consequence o f tKerapy. Abrupt increase i n urine output i n p r e t e n infants on 2nd-3rd day o f l i f e has been documented. To determine t h e e t i o l o g y o f t h i s diuresis, sequential changes i n renal function during the f i r s t f i v e days were studied i n 21 p r e t e n AGA infants with gestational age 30.254wks.
Infants were entered i n t o the study within 24hrs of l i f e and urine collections were divided i n t o 10 consecutive 12hr periods f o r 5 days. Diuresis was defined as urine volume (V) > 3mllkglhr and output/intake r a t i o 1. I 6 infants had d i s t i n c t diureSis, as defined by above c r i t e r i a . These results indicate that the low urine output i n prediuretic period i s not due t o high ADH effect (note low Uosm throughout). Diuresis i s due t o an abrupt r i s e i n GFR which i s not simply maturational but more l i k e l y hemodynamic, since GFR i s actually lower i n post diuretic period. Finally, diuresis i s due also t o decreased tubular reabsorption, most 1 i k e l y i n proximal tubule or Henle's loop, since both Na and K excretion were high during diuresis. Estimated GFR at last F/Uwas 75-109ml/min/1.73mz (rangeScr0.5-0.8mg/dl). One patient experienced reversible acute rejection at2mon, but still grew rapidly (1.25cm/mon). No younq child had CsA nephrotoxicity. TroughSCsA was always <85ng/ml. Older children grewlesswell. An 1ly.o.LRD recipient with Scr 1.8mg/dlandGFR43ml/min/1.73m2 grewO.5cm/mon during 8 mon F/U. Three older recipients (15-20y.o.:1LRD,2CAD) had bone age>l3 y.o.and demonstrated little growth (0-0.16cm/ mon) in 3-8monF/U; Scr was 1.4-2.2rng/dland~~~55-58ml/min/1.73m2. One had reversible acute rejection during wk one. Another had reversible CsA nephrotoxicity. Other CsA toxic side effects were hirsuitism (9/9), hand tremor (5/9) and asymptomatic high serum uric acid (6.7-13.5mg/dl) (9/9). Our experience suggestsCsA+PRED in pediatricTX recipientsl) permits rapid growth, especially in younq children, 2) is not limited,at least initially,by nephrotoxicity and 3) leads to early successful pediatric TX outcome.
